Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Alex "A-Rod" Rodríguez pronunciará un discurso especial en el 20º Simposio Anual de Investigación y Educación sobre la Enfermedad de Células Falciformes de la Fundación para la Investigación de la Enfermedad de Células Falciformes y la 49ª Reunión Científica Nacional sobre la Enfermedad de Células Falciformes
  • USA - English
  • USA - English

The Foundation for Sickle Cell Disease Research

News provided by

The Foundation for Sickle Cell Disease Research

Jun 04, 2026, 08:00 ET

Share this article

Share toX

Share this article

Share toX

HOLLYWOOD, Florida, 4 de junio de 2026 /PRNewswire-HISPANIC PR WIRE/ -- La Fundación para la Investigación de la Enfermedad de Células Falciformes (FSCDR) da la bienvenida al 14x All-Star de MLB y Campeón de la Serie Mundial 2009 con los Yankees de Nueva York, Alex "A-Rod" Rodríguez a su 20º Simposio Anual de Investigación y Educación sobre la Enfermedad de Células Falciformes y a su 49ª Reunión Científica Nacional sobre la Enfermedad de Células Falciformes, que tendrá lugar del 5 al 7 de junio de 2026, en el Centro de Convenciones del Condado de Broward en Fort Lauderdale, Florida. Pronunciará un discurso especial durante la Bienvenida Presidencial de Lanetta Bronté, MD, MPH, MPH, a las 11:00a. m., hora del ESTE, el 5 de junio.

"La participación de Alex Rodríguez agrega un momento significativo de visibilidad y aliento al abrir el simposio de este año", dijo Lanetta Bronté, MD, MPH, MSPH, presidenta y directora ejecutiva de FSCDR. "Estamos agradecidos de dar la bienvenida a una figura cuya plataforma puede ayudar a amplificar la conciencia, inspirar apoyo y prestar nueva atención a las necesidades de las personas y las familias que viven con la enfermedad de células falciformes".

El 20º Simposio Anual de FSCDR, con el tema "La Edad de Oro", convoca a médicos, investigadores, profesionales de la salud, líderes de la industria, partidarios de la comunidad y guerreros de células falciformes de todo Estados Unidos y de todo el mundo para debatir las preguntas clínicas y traslacionales más urgentes del campo. La agenda integra sesiones centradas en la terapéutica de precisión, los criterios de valoración centrados en el paciente, el acceso a la atención, las estrategias de salud pública, la investigación clínica y el futuro de la atención significativa de la enfermedad de células falciformes.

Otros oradores destacados incluyen al analista de ESPN y ex campeón del Super Bowl de la NFL, Ryan Clark, quien pronunciará el discurso principal de Warrior del Simposio el viernes 5 de junio, y la actriz ganadora de EGOT, productora y autora más vendida del New York Times, Viola Davis, quien se desempeña como oradora principal de la Fundación el 7 de junio.

FSCDR opera una red de 15 Centros de Excelencia de Células Falciformes en Florida y atiende a una de las poblaciones de enfermedad de células falciformes de mayor densidad en los Estados Unidos.

El Simposio anual de la organización se ha convertido en un foro internacional de primer nivel para promover la colaboración científica, la educación sanitaria, el empoderamiento de los pacientes y la innovación en el tratamiento y la atención de la enfermedad de células falciformes.

Para más información, visite la página de registro del Simposio 2026.

Acerca de la enfermedad de
células falciformes La enfermedad de células falciformes es el trastorno sanguíneo hereditario más común en los Estados Unidos, que afecta a más de 100,000 estadounidenses y millones en todo el mundo. A pesar de los importantes avances en la investigación y el tratamiento, la enfermedad ha sido históricamente insuficientemente financiada y atendida. A través de la investigación, la atención médica especializada, la educación y el apoyo centrado en la comunidad, FSCDR está trabajando para transformar los resultados y mejorar la calidad de vida de los guerreros de células falciformes y sus familias.

Acerca de la Fundación para la Investigación de la Enfermedad de Células Falciformes
La Fundación para la Investigación de la Enfermedad de Células Falciformes (FSCDR, por sus siglas en inglés) se dedica a hacer de la enfermedad de células falciformes una afección habitable y no amenazante Fundada en 2012, FSCDR se ha convertido en una red estatal de 15 Centros de Excelencia de Células Falciformes en toda Florida y está redefiniendo lo que es posible en el cuidado de células falciformes a través de la investigación integrada, la atención médica especializada, la educación de la fuerza laboral y una profunda colaboración comunitaria. FSCDR convoca a la comunidad mundial de células falciformes a través de su Simposio anual y publica el Journal of Sickle Cell Disease en asociación con Oxford University Press.

La Fundación para la Investigación de la Enfermedad de Células Falciformes
cambia la conversación. Reforma el futuro.

Contacto para los medios:
Kyla Thorpe-Brissett, MBA, MA
Vicepresidenta y Directora de Operaciones
[email protected]
844-446-5744

Logotipo - https://mma.prnewswire.com/media/2992729/The_Foundation_for_Sickle_Cell_Disease_Research_Logo.jpg

FUENTE The Foundation for Sickle Cell Disease Research

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Alex "A-Rod" Rodriguez to Deliver Special Remarks at The Foundation for Sickle Cell Disease Research's 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting

Alex "A-Rod" Rodriguez to Deliver Special Remarks at The Foundation for Sickle Cell Disease Research's 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting

The Foundation for Sickle Cell Disease Research (FSCDR) welcomes 14x MLB All-Star and 2009 World Series Champion with the New York Yankees, Alex...

Alex "A-Rod" Rodriguez to Deliver Special Remarks at The Foundation for Sickle Cell Disease Research's 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting

Alex "A-Rod" Rodriguez to Deliver Special Remarks at The Foundation for Sickle Cell Disease Research's 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting

The Foundation for Sickle Cell Disease Research (FSCDR) welcomes 14x MLB All-Star and 2009 World Series Champion with the New York Yankees, Alex...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Education

Education

Hispanic

Hispanic

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.